T. Rowe Price Investment Management
CLB icon

T. Rowe Price Investment Management’s Core Laboratories CLB Stock Holding History

T. Rowe Price Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5M Buy
1,103,895
+61,687
+6% +$1.1M 0.01% 475
2025
Q4 		$16.7M Buy
1,042,208
+134,050
+15% +$2M 0.01% 517
2025
Q3 		$11.2M Buy
908,158
+33,117
+4% +$388K 0.01% 550
2025
Q2 		$10.1M Sell
875,041
-223,587
-20% -$2.65M 0.01% 557
2025
Q1 		$16.5M Sell
1,098,628
-60,074
-5% -$1.01M 0.01% 530
2024
Q4 		$20.1M Buy
1,158,702
+46,941
+4% +$906K 0.01% 512
2024
Q3 		$20.6M Buy
1,111,761
+184,264
+20% +$3.7M 0.01% 511
2024
Q2 		$18.8M Buy
+927,497
New +$16.4M 0.01% 505

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management's CLB Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its Core Laboratories (CLB) stake by 5.9% in Q1 2026, buying an estimated $1.1M and bringing the position to 1,103,895 shares worth $18.5M. The position accounts for 0.01% of the portfolio, ranked #475.

T. Rowe Price Investment Management first reported a position in CLB in Q2 2024 and has held it in 8 quarters since. The position peaked at $20.6M in Q3 2024. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • T. Rowe Price Investment Management held 1,103,895 shares of Core Laboratories worth $18.5M as of Q1 2026.
  • T. Rowe Price Investment Management bought 61,687 Core Laboratories shares in Q1 2026, an estimated $1.1M.
  • Core Laboratories made up 0.01% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #475 holding.
  • T. Rowe Price Investment Management first reported a position in Core Laboratories in Q2 2024 and has held it in 8 quarters since.
  • T. Rowe Price Investment Management's Core Laboratories position peaked at $20.6M in Q3 2024.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.